Abstract

The differential diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH) and cerebral salt-wasting syndrome (CSWS) in patients with neurological disorders has been a perplexing clinical controversy. The purpose of this review is to summarize the characteristics and risk factors of patients with different types of neurological disorders complicated by hyponatremia (HN) and review various methods to distinguish SIADH from CSWS. Common neurological disorders with high rates of HN include subarachnoid hemorrhage (SAH), traumatic brain injuries, stroke, cerebral tumors, central nervous system (CNS) infections, and Guillain-Barré syndrome (GBS), which have their own characteristics. Extracellular volume (ECV) status of patients is a key point to differentiate SIADH and CSWS, and a comprehensive assessment of relevant ECV indicators may be useful in differentiating these two syndromes. Besides, instead of monitoring the urinary sodium excretion, more attention should be paid to the total mass balance, including Na+, K+, Cl−, and extracellular fluid. Furthermore, the dynamic detection of fractional excretions (FE) of urate before and after correction of HN and a short-term infusion of isotonic saline solution may be useful in identifying the etiology of HN. As for brain natriuretic peptide (BNP) or N-terminal prohormone of BNP (NT-proBNP), more prospective studies and strong evidence are needed to determine whether there is a pertinent and clear difference between SIADH and CSWS.

Highlights

  • Hyponatremia (HN), which is defined as serum sodium concentration

  • No single and simple cause is involved in the pathophysiology of cerebral salt-wasting syndrome (CSWS)

  • With respect to the classical manifestations considered in the differential diagnosis of CSWS and SIADH, not all patients with increased BNP levels should be diagnosed with CSWS

Read more

Summary

Frontiers in Neuroscience

The differential diagnosis of syndrome of inappropriate antidiuretic hormone secretion (SIADH) and cerebral salt-wasting syndrome (CSWS) in patients with neurological disorders has been a perplexing clinical controversy. The purpose of this review is to summarize the characteristics and risk factors of patients with different types of neurological disorders complicated by hyponatremia (HN) and review various methods to distinguish SIADH from CSWS. Common neurological disorders with high rates of HN include subarachnoid hemorrhage (SAH), traumatic brain injuries, stroke, cerebral tumors, central nervous system (CNS) infections, and Guillain-Barré syndrome (GBS), which have their own characteristics. Extracellular volume (ECV) status of patients is a key point to differentiate SIADH and CSWS, and a comprehensive assessment of relevant ECV indicators may be useful in differentiating these two syndromes.

INTRODUCTION
THE PATHOLOGICAL MECHANISM AND DIAGNOSTIC CRITERIA OF SIADH AND CSWS
CNS infections
No further evidence was found
Traumatic Brain Injury
Cerebral Tumors
CNS Infections
DIFFERENTIATING SIADH FROM CSWS IN PATIENTS WITH NEUROLOGICAL DISORDERS
Increased Increased Increased Decreased Decreased
Can BNP Be Used as an Indicator in Diagnosing?
Before correction of HN After correction of HN
The Feasibility of Diagnostic Treatment
SUMMARY AND CONCLUSIONS
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call